Cited by 38Hepatitis C virus researchHIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.

Lockart, Ian, Matthews, Gail V., Danta, Mark·2019·Current Opinion in Infectious Diseases

Open this paper in CoChat — free account

Abstract

PURPOSE OF REVIEW: The scale-up of direct-acting antiviral (DAA) therapy and introduction of preexposure prophylaxis (PrEP) has changed the epidemiology of sexually acquired hepatitis C virus (HCV) amongst HIV-positive and HIV-negative MSM. RECENT FINDINGS: Sexually acquired HCV continues to occur predominantly amongst HIV-positive MSM. Despite an increased uptake of DAA therapy the incidence of acute HCV has not declined consistently amongst HIV-positive MSM, likely a result of high infection and reinfection rates. Increasing cases of sexually acquired HCV have been reported amongst HIV-negative MSM accessing PrEP. Despite a lower prevalence of HCV at baseline, HIV-negative MSM accessing PrEP have an equally high overall incidence of HCV compared with HIV-positive MSM during follow-up. Behavioural factors (high-risk sexual behaviours and sexualized drug use) appear to be driving this HCV epidemic amongst MSM and effective behavioural interventions and early identification of reinfections are essential to control the HCV epidemic amongst MSM. SUMMARY: An improved understanding of the epidemiology of sexually acquired HCV will allow implementation of more effective public health interventions to control the transmission of HCV amongst HIV-positive and HIV-negative MSM.

Integrity signals

Registry

Crossref · 10.1097/qco.0000000000000515

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J., Negro, F., Aghemo, A., Berenguer, M., Dalgård, O., Dusheiko, G. M., Marra, F., Puoti, M., & Wedemeyer, H. H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,846
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Panel, A.-I. H. G., Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K., Naggie, S., Vargas, H. E., Aronsohn, A. I., Bhattacharya, D., Broder, T., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy585 · Cited by 734
Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Naggie, S., Cooper, C., Saag, M. S., Workowski, K., Ruane, P. J., Towner, W. J., Marks, K., Luetkemeyer, A. F., Baden, R. P., Sax, P. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501315 · Cited by 467
Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis.
Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Cornelisse, V. J., Doyle, J. S., & Stoové, M. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy182 · Cited by 447
Hepatitis C
Webster, D. P., Klenerman, P., & Dusheiko, G. M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62401-6 · Cited by 436
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
Rockstroh, J. K., Nelson, M. R., Katlama, C., Lalezari, J. P., Mallolas, J., Bloch, M., Matthews, G. V., Saag, M. S., Zamor, P. J., Orkin, C. M., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00114-9 · Cited by 304
Self-citation
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.
Terrault, N. A., Dodge, J. L., Murphy, E. L., Tavis, J. E., Kiss, A., Levin, T. R., Gish, R. G., Busch, M. P., Reingold, A. L., & Alter, M. J. (2013) · Hepatology · doi:10.1002/hep.26164 · Cited by 263
Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics.
Hegazi, A., Lee, M., Whittaker, W., Green, S., Simms, R., Cutts, R., Nagington, M., Nathan, B., & Pakianathan, M. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416651229 · Cited by 231
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
Hagan, H., Jordan, A. E., Neurer, J., & Cleland, C. M. (2015) · AIDS · doi:10.1097/qad.0000000000000834 · Cited by 230

Show all 45 references

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Horberg, M. A., Thompson, M., Agwu, A. L., Colasanti, J. A., Haddad, M. S., Jain, M. K., McComsey, G. A., Radix, A., Rakhmanina, N. Y., Short, W. R., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae479 · Cited by 169
Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015
for the ANRS-Prevagay group, Vaux, S., Chevaliez, S., Saboni, L., Sauvage, C., Sommen, C., Barin, F., Alexandre, A. F., Jauffret‐Roustide, M., Lot, F., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3945-z · Cited by 53
Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis
Karimi, S. E., Bayani, A., Higgs, P., Bayat, A., Hemmat, M., Ahounbar, E., Armoon, B., & Fakhri, Y. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00306-1 · Cited by 30
The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment
Lourenço, L., Kelly, M., Tarasuk, J., Stairs, K., Bryson, M., Popovic, N., & Aho, J. (2021) · Canada Communicable Disease Report · doi:10.14745/ccdr.v47i12a01 · Cited by 29
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
Gras, J., Mahjoub, N., Charreau, I., Cotte, L., Tremblay, C., Chas, J., Raffi, F., Cua, E., Guillon, B., Guigue, N., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002364 · Cited by 28
Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
Sun, H., Chiang, C., Huang, S., Guo, W.-J., Chuang, Y., Huang, Y., Yang, C., Su, L., Chen, Y.-T., Chen, Y.-W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02437-21 · Cited by 21
Protect MSM from HIV and other sexually transmitted diseases by providing mobile health services of partner notification: protocol for a pragmatic stepped wedge cluster randomized controlled trial
Yan, X., Li, Y., Su, H., Xing, Y., Zhang, B., Lu, Z., & Jia, Z. (2020) · BMC Public Health · doi:10.1186/s12889-020-09162-x · Cited by 19
Are we on the precipice of a new epidemic? Risk for hepatitis C among HIV-negative men-, trans women-, and trans men- who have sex with men in the United States
Grov, C., Westmoreland, D. A., Carrico, A. W., & Nash, D. (2020) · AIDS Care · doi:10.1080/09540121.2020.1739204 · Cited by 18
Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis
Tabatabavakili, S., Aleyadeh, W., Cerocchi, O., Janssen, H. L. A., Hansen, B. E., Bogoch, I. I., & Feld, J. J. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.006 · Cited by 15
Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study
Marshall, A. D., Martinello, M., Treloar, C., & Matthews, G. V. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103828 · Cited by 12
Self-citation
Decreasing prevalence and stagnating incidence of Hepatitis C‐co‐infection among a cohort of HIV‐1‐positive patients, with a majority of men who have sex with men, in Germany, 1996–2019
Krings, A., Schmidt, D., Meixenberger, K., Bannert, N., Münstermann, D., Tiemann, C., Kollan, C., & Gunsenheimer‐Bartmeyer, B. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13670 · Cited by 12
Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region
Filho, A. B. D. O., Aires, D. W. F., Cavalcante, N. D. S., Raiol, N. C., Lisboa, B. L. A., Frade, P. C. R., da Costa, L. M., Pinheiro, L. M. D. L., Machado, L. F. A., Martins, L. C., et al. (2019) · Pathogens · doi:10.3390/pathogens8040236 · Cited by 10
Increasing hepatitis B vaccination coverage and decreasing hepatitis B co‐infection prevalence among people with HIV ‐1 in Germany, 1996–2019. Results from a cohort study primarily in men who have sex with men
Krings, A., Schmidt, D., Kollan, C., Meixenberger, K., Bannert, N., Münstermann, D., Tiemann, C., Bremer, V., Gunsenheimer‐Bartmeyer, B., & the German HIV‐1 Seroconverter Study Group (2023) · HIV Medicine · doi:10.1111/hiv.13554 · Cited by 7
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study
Carson, J. M., Barbieri, S., Cunningham, E. B., Mao, E., van der Valk, M., Rockstroh, J. K., Hellard, M. E., Kim, A. Y., Bhagani, S. R., Feld, J. J., et al. (2023) · Journal of the International AIDS Society · doi:10.1002/jia2.26168 · Cited by 6
Self-citation
Usability and acceptability of oral fluid- and blood-based hepatitis C virus self-testing among the general population and men who have sex with men in Malaysia
Chan, H., Sem, X., Reipold, E. I., Selvam, S. B. P., Salleh, N. A., Gani, A. H. B. M., Fajardo, E., Shilton, S., & Hassan, M. R. A. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001770 · Cited by 6
Self-Reported Sexual Behavioral Similarities and Differences Among Young Men Who Have Sex With Men With Childhood Sexual Abuse Histories: A Qualitative Exploratory Study
Emetu, R. E., Yarber, W. L., Sherwood‐Laughlin, C., & Brandt, A. S. (2020) · American Journal of Men s Health · doi:10.1177/1557988320949355 · Cited by 6
HCV knowledge, disclosure practices, and risk perceptions among gay and bisexual men who do and do not engage in group sex while using drugs
Brener, L., Murphy, D., Cama, E. J., Murray, J., Fraser, N., & Ellard, J. (2020) · AIDS Care · doi:10.1080/09540121.2020.1757023 · Cited by 6
Pharmacology Update for the Treatment of Hepatitis C Virus
Hopkins, L. W., Dunlap, T., & Cline, H. (2020) · Nursing Clinics of North America · doi:10.1016/j.cnur.2020.06.008 · Cited by 6
Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services
Clementi, E., Bartlett, S., Otterstatter, M. C., Buxton, J. A., Wong, S., Yu, A., Butt, Z. A., Wilton, J., Pearce, M., Jeong, D., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.035 · Cited by 6
Viral Hepatitis
Neuhoff, B. K. (2025) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000938 · Cited by 6
Hepatitis C antibody prevalence and active hepatitis C infection in HIV-negative gay, bisexual, and other men who have sex with men in Barcelona and Madrid, Spain (March 2018-March 2021)
Palma, D., Gutiérrez, M. A., de Olalla, P. G., Guerras, J. M., Pericas, C., Garcia, J. N., Barberà, M. J., Ayerdi, O., García, M. V., Román-Urrestarazu, A., et al. (2023) · IJID Regions · doi:10.1016/j.ijregi.2023.07.001 · Cited by 4
Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study
Künzler‐Heule, P., Schmidt, A. J., Fierz, K., Battegay, M., Engberg, S. J., Kouyos, R. D., Nöstlinger, C., Stöckle, M., Béguelin, C., Delaloye, J., et al. (2023) · AIDS Care · doi:10.1080/09540121.2023.2208318 · Cited by 4
Exploring Awareness of HCV Among Sexual-Minority Black Generation Millennials and Gen Z: a Qualitative Study
The PPOWER Project Team, D’Anna, L. H., Washington, T. A., Cabudol, M., Canjura, C., & Owens, J. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-019-00684-8 · Cited by 3
Hepatitis C: von der Diagnose zur weltweiten Virus-Elimination
Schmitt, A., & Sarrazin, C. (2024) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2057-1797 · Cited by 2
Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV‐infected men in a community‐based primary care setting
Chen, Y., Thio, C. L., Kamangar, F., Cox, A. L., & Wiberg, K. J. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13354 · Cited by 2
Sexually Transmitted Diseases (STDs)
Cocci, A., & Romano, A. (2022) · Management of urology · doi:10.1007/978-3-031-12049-7_17 · Cited by 2
Hepatitis C testing among three distinct groups of gay, bisexual and other men who have sex with men: a cross-sectional study in the Celtic nations
Whiteley, D., Strongylou, D. E., Brown, S. R., Vickerman, P. T., & Frankis, J. S. (2023) · Sexually Transmitted Infections · doi:10.1136/sextrans-2023-055758 · Cited by 2
Hepatitis C prevalence among men who have sex with men in Central Brazil
de Andrade, A. A., Silva, Á. M. D. C. E., Carneiro, M. A. D. S., Teles, S. A., & Martins, R. M. B. (2019) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2019.06.008 · Cited by 2
Impact of PrEP on a STI clinic in a Belgian context: a provider’s perspective
Apers, L., Vanhamel, J., Caluwaerts, S., Platteau, T., Kenyon, C. R., & Florence, É. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1767995 · Cited by 2
Hepatitis C Virus Seroprevalence, Incidence, and Screening Patterns in Ontario Preexposure Prophylaxis Users
McGarrity, M. W., Lisk, R., MacPherson, P., Knox, D. C., Woodward, K. S., Reinhart, J., Macleod, J., Bogoch, I. I., Clatworthy, D., Biondi, M. J., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf014 · Cited by 1
Genotypes of human papillomavirus and clinical pathological features among patients with anal carcinoma in North-western Tanzania
Ottoman, O., David, F., Nyansuku, J., James, M., Minja, C. A., Mukerebe, C., Leeyio, T. R., Kidenya, B. R., & Rambau, P. (2026) · Infectious Agents and Cancer · doi:10.1186/s13027-026-00754-7 · Cited by 1
Pengaruh Hubungan Laki-laki Seks dengan Laki-Laki dengan Munculnya Risiko Infeksi Menular Seksual Pada Pria Perilaku Seksual Promiskuitas
Kosasih, R., Wijaya, D. A., Nathaniel, F., & Firmansyah, Y. (2023) · Journal of Educational Innovation and Public Health · doi:10.55606/innovation.v1i3.1494 · Cited by 1
Expanded or Risk Factor-Based Annual Screening for Hepatitis C Virus (HCV) Among Persons With HIV: Which Is the Best Approach?
Hao, R. M., Brooks, R. P., Zelenev, A., Spinner, G. F., Barakat, L., & Villanueva, M. S. (2023) · Health Promotion Practice · doi:10.1177/15248399231169794 · Cited by 1
Hepatitis C in people who inject drugs in the Stockholm needle exchange program : incidence, spontaneous clearance and change in risk behaviour
Kåberg, M. (2019) · Figshare · Cited by 1
L’épidémie d’hépatite C au Canada : un aperçu des tendances récentes en matière de surveillance, de consommation de drogues injectables, de réduction des méfaits et de traitement
Lourenço, L. C., Kelly, M., Tarasuk, J., Stairs, K., Bryson, M., Popovic, N., & Aho, J. (2021) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v47i12a01f
Additional file 2 of Protect MSM from HIV and other sexually transmitted diseases by providing mobile health services of partner notification: protocol for a pragmatic stepped wedge cluster randomized controlled trial
Yan, X., Li, Y., Su, H., Xing, Y., Zhang, B., Lu, Z., & Jia, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12655316
Additional file 1 of Protect MSM from HIV and other sexually transmitted diseases by providing mobile health services of partner notification: protocol for a pragmatic stepped wedge cluster randomized controlled trial
Yan, X., Li, Y., Su, H., Xing, Y., Zhang, B., Lu, Z., & Jia, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12655313

Authors: Lockart, I., Matthews, G. V., & Danta, M.
Affiliations: St Vincent's Hospital Sydney (AU)
UNSW Sydney (AU)
Corresponding author: Danta, Mark
ORCID: Lockart, Ian
Matthews, Gail V.
Danta, Mark
Venue: Current Opinion in Infectious Diseases
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2019-02
Volume: 32
Issue: 1
Pages: 31-37
ISSN: 0951-7375 (ISSN-L)
1473-6527
DOI: 10.1097/qco.0000000000000515
OpenAlex: W2904186291
Cited by: 37
References: 45
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 12 · 2019: 5
FWCI: 0.71
Type: journal article
Language: en
Open access: closed
Locations: Current Opinion in Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: hepatitis C virus, sexually transmitted infections, men who have sex with men, HIV-positive MSM, HIV-negative MSM, pre-exposure prophylaxis, direct-acting antivirals, HCV reinfection, HCV incidence, sexual risk behavior, chemsex, HCV epidemiology, behavioral interventions
MeSH terms: Antiviral Agents, Hepatitis C, Humans, Male, Sexually Transmitted Diseases, Viral, HIV Infections, Homosexuality, Male, Epidemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks